Cargando…
Structure–Activity Relationship for the First-in-Class Clinical Steroid Sulfatase Inhibitor Irosustat (STX64, BN83495)
Structure–activity relationship studies were conducted on Irosustat (STX64, BN83495), the first steroid sulfatase (STS) inhibitor to enter diverse clinical trials for patients with advanced hormone-dependent cancer. The size of its aliphatic ring was expanded; its sulfamate group was N,N-dimethylate...
Autores principales: | Woo, L W Lawrence, Ganeshapillai, Dharshini, Thomas, Mark P, Sutcliffe, Oliver B, Malini, Bindu, Mahon, Mary F, Purohit, Atul, Potter, Barry V L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262147/ https://www.ncbi.nlm.nih.gov/pubmed/21990014 http://dx.doi.org/10.1002/cmdc.201100288 |
Ejemplares similares
-
C-3- and C-4-Substituted Bicyclic Coumarin
Sulfamates as Potent Steroid Sulfatase Inhibitors
por: Ganeshapillai, Dharshini, et al.
Publicado: (2018) -
Novel Anti-Acanthamoebic Activities of Irosustat and STX140 and Their Nanoformulations
por: Siddiqui, Ruqaiyyah, et al.
Publicado: (2023) -
Inhibition of Steroid Sulfatase Activity in Endometriotic Implants by STX64 (667Coumate): A Potential New Therapy
por: Fusi, L., et al.
Publicado: (2008) -
IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer
por: Palmieri, Carlo, et al.
Publicado: (2017) -
Aromatase and Dual Aromatase-Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates
por: Wood, Paul M, et al.
Publicado: (2011)